Clinical Trial Update: Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the pharmacodynamics of ticagrelor and clopidogrel after thrombolysis in patients with acute coronary syndromes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Medical Center of South Arkansas | Conditions: Acute ST Segment Elevation Myocardial Infarction, Acute Coronary Syndrome | Phase 4 | Status: WITHDRAWN